Kos
Kos BioVentures (ΑΚΕΣ) Website Manager Kos Biotechnology Partners Α.Ε.Δ.Α.K.E.Σ. Size €39,0m ESTABLISHMENT Q4 2025 Investment Focus Early stage and scale-up companies in biotechnology, therapeutics, pharmaceutical, health,
Kos BioVentures (ΑΚΕΣ) Website Manager Kos Biotechnology Partners Α.Ε.Δ.Α.K.E.Σ. Size €39,0m ESTABLISHMENT Q4 2025 Investment Focus Early stage and scale-up companies in biotechnology, therapeutics, pharmaceutical, health,
ELIKONOS 3 S.C.A. SICAV-RAIF Website Manager Elikonos Capital AIFM Size €175,0m ESTABLISHMENT Q4 2025 Investment Focus Greek SMEs and mid-caps with strong growth potential, deploying
BRAIN GAIN A.K.E.S Website Manager Metavallon Partners Venture Capital Management S.A. Size €5,1m ESTABLISHMENT Q4 2025 Investment Focus Pre revenue / pre-seed start-ups in 4IR
SMERemediumCap II Website Manager SMERemediumCap Limited Size €200,0m ESTABLISHMENT Q4 2025 Investment Focus SMEs and Mid-Caps in need of restructuring/reorganization, who engage primarily in manufacturing

Big Pi Growth I A.K.E.S. Website Manager Big Pi Venture Capital Management S.A. Size €136,0m ESTABLISHMENT Q2 2025 Investment Focus SMEs or Small Mid-Caps at

Catapult Growth Partners A.K.E.S Website Manager Catapult Growth Partners Venture Capital Management S.A. Size €40,0m ESTABLISHMENT Q1 2025 Investment Focus Sector agnostic, with focus primarily

Golden Age Capital Private Equity Fund I (A.K.E.Σ) Website Manager Golden Age Capital Α.Ε.Δ.Α.Κ.Ε.Σ Size €151,5m ESTABLISHMENT Q1 2025 Investment Focus Sector-agnostic with focus on

The Hellenic Development Bank of Investments S.A. (ex TANEO), in its role as the Equity Platform for the National Recovery and Resilience Plan “Greece 2.0”,

The Hellenic Development Bank of Investments S.A. (HDBI ex TANEO), implementing the Equity Platform tool of the National Recovery and Resilience Plan “Greece 2.0”, announces